Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir.

Article Details

Citation
Copy to clipboard

Ridruejo E

Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir.

World J Gastroenterol. 2014 Jun 21;20(23):7169-80. doi: 10.3748/wjg.v20.i23.7169.

PubMed ID
24966587 [ View in PubMed
]
Abstract

Results from phase III clinical trials clearly demonstrate the efficacy and safety of entecavir and tenofovir in the controlled environment of randomized clinical studies. There are several studies with both drugs performed in clinical practice (also called "real life studies"). Despite the pros and cons, studies performed in real life conditions represent everyday practice and add important information about long term treatment effectiveness and safety in this clinical setting. This review shows that patients treated with first line nucleos(t)ide analogs at referral centres, with good clinical follow-up and adherence to international guidelines, can achieve high treatment response rates with a very low rate of adverse events.

DrugBank Data that Cites this Article

Drugs